Company Overview

Company OverviewCHA Biotech History

· Filled IND application with MFDS for phase I/IIa study of CordSTEM®-DD
(Disk Degeneration)
· Filed IND application with MFDS for phase I study of CBT101-Solid Cancer

   
2020

2019
   

· Sang Hoon Oh appointed as new CEO
· Sold stake in US Subsidiary(Stem Cell & Regenerative Medicine International,
  Inc.)

· JJae Hoon Song appointed as Chairman of CHA Bio Group and CHA Biotech
· Acquisition of profit-making businesses from subsidiaries and affiliate
(Businesses of Bio-based raw materials, IT service, Sales for CHA group employees)
· Jong Sung Choi appointed as Co-CEO
· Physical Division: Establishment of CHA Biolab(CMO and basic research business)
· Global phase II clinical trial for Intermittent Claudication completed
(CHA Biotech & Pluristem Therapeutics, PLX-PAD)

   
2018

2017
   

· Young Wook Lee appointed as Co-CEO
· Phase I/IIa clinical trial for Stroke conducted in Korea completed(eCASs)
· Injection to patients in global phase II clinical trial for Intermittent Claudication
  completed (CHA Biotech & Pluristem Therapeutics, PLX-PAD)

· Injection to patients in phase I/IIa clinical trial for Stroke conducted in Korea
completed(eCASs)
· Phase I IND approval for Cartilage Defect received from MFDS in Korea(eCASs)
· Certificate of Venture Enterprise received
· Phase I/IIa IND approval for Disk Degeneration received from MFDS in Korea(eCASs)

   
2016

2015
   

· Phase I/IIa IND approval for Alzheimer’s Disease received from MFDS in Korea
  (ePACs)
· CHAUM Immune Therapy Center opened
· 4th International Cancer Conquer Seminar opened
· Phase I clinical trial for Stargardt Macular Degeneration conducted in Korea
   completed(MA09-hRPE)

 
CEO Message
Vision
History
Overseas Corporations
Affiliated Companies
Business Overview
Cord Blood Banking Business
Bio Insurance Business
CHAUM Business(Non-medical)
IT Business
Other Business
CHA Biotech R&D Center
R&D Pipeline
Current Status of Clinical Trials
Patent Grants (Korea/Overseas)
Scientific Publications
Corporate Filings
Stock Information
IR Presentations